2021-06-14 |
11 |
Counterclaim AND Answer to Complaint |
civil action for patent infringement of United States Patent No.
8,642,079 (“the ’079 patent”) arising under…) (“Complaint”) concerning U.S. Patent No. 8,642,079 (“the ’079 patent”).
…that one or more claims of U.S. Patent No.
8,642,079 (“the ’079 patent”) is invalid and/or not infringed…resolution of patent disputes by
authorizing a patent owner to sue an ANDA applicant for patent infringement…be an action for
patent infringement arising under the Food and Drug Laws and Patent Laws of the United |
External link to document |
2021-11-16 |
18 |
Judgment - Consent |
that United States Patent Nos. 8,642,079 ("the '079 patent");
6,245,819 ("the '…x27;819 patent"); and 8,236,861 ("the ' 861 patent") are patentable, valid and
enforceable…expiration of the ' 079 patent, the ' 819 patent, and the ' 861 patent, would
infringe one …claims of the ' 079 patent, the ' 819 patent and the '861 patent.
3. Except…expiration of the ' 079 patent, the '819 patent, and the ' 861 patent, Hetero and its successors |
External link to document |
2021-11-16 |
19 |
Patent/Trademark Report to Commissioner of Patents |
that United States Patent Nos. 8,642,079 ("the '079 patent");
6,245,819 ("the '…x27; 819 patent"); and 8,236,861 ("the ' 861 patent") are patentable, valid and
enforceable…expiration of the '079 patent, the ' 819 patent, and the '861 patent, would
infringe one or…claims of the '079 patent, the '819 patent and the '861 patent.
3. Except…expiration of the ' 079 patent, the ' 819 patent, and the ' 861 patent, Hetero and its successors |
External link to document |
2021-04-14 |
4 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,642,079. (kmd) (Entered: 04…
17 November 2021
1:21-cv-00538
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |